SCOR cites benefit of early issuance with new Atlas Capital 2025-1 catastrophe bond – Go Health Pro

SCOR cites benefit of early issuance with new Atlas Capital 2025-1 catastrophe bond – Go Health Pro

French reinsurer SCOR has cited the benefits of early issuance as being a key factor behind the successful placement of its latest catastrophe bond, saying this helped them access currently favourable market conditions with the recent $240 million Atlas Capital DAC (Series 2025-1).SCOR returned to the catastrophe bond market in March with its latest Atlas … Read more

SCOR secures 20% upsized $240m of retrocession from Atlas Capital 2025-1 cat bond – Go Health Pro

SCOR secures 20% upsized 0m of retrocession from Atlas Capital 2025-1 cat bond – Go Health Pro

Global reinsurance company SCOR has now secured the 20% upsized target for $240 million in fully-collateralized retrocession from its new Atlas Capital DAC (Series 2025-1) catastrophe bond, with the notes now priced 6.5% below the mid-point of initial spread guidance, Artemis has learned.SCOR returned to the cat bond market in March, with an initial target … Read more

Beijing launches $72bn capital injections at biggest banks – Go Health Pro

Beijing launches bn capital injections at biggest banks – Go Health Pro

Stay informed with free updates Simply sign up to the Chinese business & finance myFT Digest — delivered directly to your inbox. Four of China’s biggest banks will raise a combined Rmb520bn ($72bn) through share sales to investors including the Ministry of Finance, as Beijing seeks to shore up its vast banking sector against pressing … Read more

Japan plays host to a clash of capital and culture – Go Health Pro

Japan plays host to a clash of capital and culture – Go Health Pro

Unlock the Editor’s Digest for free Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. When activist investor Oasis Management called for change at Japanese consumer goods giant Kao — proposing boardroom reform through the election of outside directors and long term incentives — the response was clear and decisive. … Read more

RenRe consistently sees greater demand for Capital Partners investments than it can satisfy: CEO – Go Health Pro

RenRe consistently sees greater demand for Capital Partners investments than it can satisfy: CEO – Go Health Pro

RenaissanceRe, the Bermuda headquartered global reinsurer and third-party reinsurance capital manager, has built a “deep and persistent moat” around its fee income business, CEO Kevin O’Donnell believes, saying that demand from investors for access to its Capital Partners strategies is often greater than it can satisfy.Writing in his annual letter to shareholders, Kevin O’Donnell explained … Read more